Search Results - "Modemann F"

Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Authors: Krüger, Katja Gabdoulline, Razif Wichmann, Martin et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p2993. 17p.

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Authors: Alati, Caterina Pitea, Martina Molica, Matteo et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p107. 21p.

Downregulation of S6 Kinase and Hedgehog–Gli1 by Inhibition of Fatty Acid Synthase in AML with FLT3-ITD Mutation.

Authors: Kebenko, Maxim Zhuang, Ruimeng Hoffer, Konstantin et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 12, p5721. 21p.

Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study.

Authors: Longo, Ermelinda Palumbo, Fanny Erika Duminuco, Andrea et al.

Source: Journal of Clinical Medicine. 8/1/2025, Vol. 14 Issue 15, p5586. 19p.

Transferable automatic hematological cell classification: Overcoming data limitations with self-supervised learning.

Authors: Wenderoth L Asemissen AM Modemann F et al.

Source: Computer methods and programs in biomedicine [Comput Methods Programs Biomed] 2025 Mar; Vol. 260, pp. 108560. Date of Electronic Publication: 2024 Dec 09.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8506513 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7565 (Electronic) Linking ISSN: 01692607 NLM ISO Abbreviation: Comput Methods Programs Biomed Subsets: MEDLINE

A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.

Authors: Shahswar R Gabdoulline R Krueger K et al.

Source: Leukemia [Leukemia] 2025 Mar; Vol. 39 (3), pp. 614-622. Date of Electronic Publication: 2025 Jan 08.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Advances in Cell Therapy for Chronic Graft-versus-Host Disease: Prophylactic and Therapeutic Perspectives.

Authors: Taghinejad Z Moradi N Talebi A et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2026 May 05; Vol. 26 (1). Date of Electronic Publication: 2026 May 05.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

CHRNB4-Mediated Neuroactive Signaling Rewiring Drives Adaptive Resistance to BCL-2 Inhibition in Acute Myeloid Leukemia.

Authors: Koyama, Hiroaki Seo, Sachiko Tse, William et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1187. 20p.

Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid.

Authors: Harrer, Dennis Christoph Lüke, Florian Pukrop, Tobias et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p1067. 27p.

Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML).

Authors: Schönrock, Martin Sonnemann, Piet Michalowski, Nina et al.

Source: Cancers. Nov2024, Vol. 16 Issue 22, p3872. 14p.

From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies.

Authors: Golla, Upendarrao Patel, Satyam Shah, Nyah et al.

Source: Cancers. Oct2024, Vol. 16 Issue 20, p3454. 22p.

Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategies.

Authors: Liu X Zhang D Xu L et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Mar 31. Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

The risk of digestive tract complications in patients with gastrointestinal lymphoma: a propensity score study.

Authors: Zhao Y Zhang X Zhou Y et al.

Source: BMC gastroenterology [BMC Gastroenterol] 2026 Mar 03; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

hGFAP-mediated GLI2 overexpression leads to early death and severe cerebellar malformations with rare tumor formation.

Authors: Niesen J Hermans-Borgmeyer I Krüger C et al.

Source: IScience [iScience] 2023 Jul 28; Vol. 26 (9), pp. 107501. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy.

Authors: Riet T Lennartz S Bösing N et al.

Source: Experimental hematology & oncology [Exp Hematol Oncol] 2026 Jun 18; Vol. 15 (1). Date of Electronic Publication: 2026 Jun 18.

Publication Type: Letter

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE

MCL1 inhibition to enhance the efficacy of MYB targeting in pediatric acute myeloid leukemia.

Authors: Tsakaneli A Che N Virely C et al.

Source: Cell death & disease [Cell Death Dis] 2026 May 13; Vol. 17 (1). Date of Electronic Publication: 2026 May 13.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

Clinical and biological advances of critical complications in acute myeloid leukemia.

Authors: Costa, Alessandro Scalzulli, Emilia Carmosino, Ida et al.

Source: Leukemia & Lymphoma. Mar2025, Vol. 66 Issue 3, p400-419. 20p.

XPO1/Exportin-1 in Acute Myelogenous Leukemia; Biology and Therapeutic Targeting.

Authors: Bruserud, Øystein Selheim, Frode Hernandez-Valladares, Maria et al.

Source: Biomolecules (2218-273X). Feb2025, Vol. 15 Issue 2, p175. 29p.

Comorbidities and mortality in colistin-resistant gram-negative infections among hospitalized patients in Qassim, Saudi Arabia.

Authors: Almutairi MS Albulaihed M Almutairi F et al.

Source: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2026 Feb 27; Vol. 34 (1). Date of Electronic Publication: 2026 Feb 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer in collaboration with King Saud University Country of Publication: Netherlands NLM ID: 9705695 Publication Model: Electronic Cited Medium: Print ISSN: 1319-0164 (Print) Linking ISSN: 13190164 NLM ISO Abbreviation: Saudi Pharm J Subsets: PubMed not MEDLINE

Mebendazole effectively overcomes imatinib resistance by dual-targeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells.

Authors: Li Yang Zhuanyun Du Yuhang Peng et al.

Source: Korean Journal of Physiology & Pharmacology. Jan2025, Vol. 29 Issue 1, p67-81. 15p.